Increasing peak expiratory flow time in amyotrophic lateral sclerosis

Chest

Volumn 127, Issue 1, 2005, Pages 156-160

  Wilson, Steven R ^a   Quantz, Mackenzie A ^a   Strong, Michael J ^a   Ahmad, Dildar ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Amyotrophic lateral sclerosis; FVC; Peak expiratory flow rate; Pulmonary function testing; Respiratory muscles

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BREATHING MUSCLE; BULBAR PARALYSIS; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; KRUSKAL WALLIS TEST; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VENTILATION; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; AGED; MIDDLE AGED; PATHOPHYSIOLOGY; VITAL CAPACITY;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; RESPIRATORY MUSCLES; VITAL CAPACITY;

EID: 13844309840     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.1.156     Document Type: Article

References (16)

1. Vitacca M, Clini E, Facchetti D, et al. Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis. Eur Respir J 1997; 10:1614-1621
2. Schiffman P, Belsh J. Pulmonary function at diagnosis of amyotrophic lateral sclerosis: rate of deterioration. Chest 1993; 103:509-513
3. Lechtzin N, Rothstein J, Clawson L, et al. Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment. Amyotroph Lateral Scler Other Motor Neuron Disord 2002; 3:5-13
4. Stambler N, Charatan M, Cedarbaum J. Prognostic indicators of survival in ALS: ALS CNTF Treatment Study Group. Neurology 1998; 50:66-72
5. Armon C, Moses D. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci 1998; 160(suppl):S37-S41
6. Magnus T, Beck M, Giess R, et al. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002; 25:709-714
7. Miller M, Pederson O. The rise and dwell time for peak expiratory flow in patients with and without airflow limitation [abstract]. Eur Respir J 1994; 7(suppl):53s
8. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1994; 152:1107-1136, 1285-1298
9. Pederson O. The Peak Flow Working Group: physiological determinants of peak expiratory flow. Eur Respir J 1997; 10(Suppl):11s-16s
10. Quanjer P, Lebowitz I, Gregg M, et al. Peak expiratory flow: conclusions and recommendations of a Working Party of the European Respiratory Society. Eur Respir J 1997; 10(suppl): 2s-8s
11. Kano S, Burton D, Lanteri C, et al. Determination of peak expiratory flow. Eur Respir J 1997; 6:1347-1352
12. Consensus guidelines for the design and implementation of clinical trials in ALS: 2nd Airlie House Workshop 1998; Subcommittee on Motor Neuron Diseases of the World Federation of Neurology Research Group on Neuromuscular Diseases. Available at: http://www.wfnals.org/guidelines/1998airlieclintrial/airlie1998. htm. Accessed October 6, 2004
13. Kreitzer S, Saunders N, Tyler H, et al. Respiratory muscle function in amyotrophic lateral sclerosis. Chest 1978; 73(suppl):266-267
14. Enright P, Linn W, Avol E, et al. Quality of spirometry test performance in children and adolescents. Chest 2000; 118: 665-671
15. Brach B. Expiratory flow patterns in amyotrophic lateral sclerosis. Chest 1979; 75:648-649
16. Garcia-Pachon E, Marti J, Mayos M, et al. Clinical significance of upper airways dysfunction in motor neuron disease. Thorax 1994; 49:896-900